James Watson’s Death Sparks Debate on His Controversial Legacy
James Watson, the Nobel laureate renowned for co-discovering the structure of DNA, passed away last…
Newswire
AI Chatbots in Mental Health: A Growing Concern for Users
The increasing integration of AI chatbots into daily life has raised significant concerns regarding their…
Medicare Premiums to Jump 10% Heading into 2026
Most Medicare enrollees will face premiums that are 10% higher next year, creating budget anxiety…
AI Model Could Boost Liver Transplant Efficiency by Predicting Donor Death Timing
Researchers at Stanford Medicine have developed a machine learning model that significantly enhances the efficiency…
FDA Updates Sarepta’s Duchenne Gene Therapy Label, Requests Postmarketing Study
The FDA has revised the label for Sarepta’s Duchenne muscular dystrophy gene therapy, Elevidys, introducing…
FDA Initiates Closed-Door Negotiations on Generic Drug User Fees
The FDA and generic drug manufacturers commenced closed-door negotiations last month regarding the fourth round…
Pfizer Closes $10 Billion Metsera Deal
Pfizer has finalized its acquisition of Metsera for $10 billion, a strategic move aimed at…
FDA’s Office of Generic Drugs Ensures Access to Quality Generics
The FDA’s Office of Generic Drugs (OGD) plays a critical role in maintaining the integrity…
AI Meets Genetic Agency at Dyno GATC 2025
BOSTON – Artificial intelligence (AI) emerged as a pivotal theme at the recent Genetic Agency…
UK Considers Raising NICE Cost-Effectiveness Threshold Amidst Drug Spending Debate
The UK is contemplating an increase in the National Institute for Health and Care Excellence…